latest news releases from the newsroom
Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. Achieves New Company Record Ahead of Schedule With 5,000 Genetic Insertions in a Single Week
EAST LANSING, Mich., Feb. 10, 2009 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCBB:KBLB) is pleased to announce that Dr. Fraser's research team recently accomplished five thousand genetic transfers in a single week using the newly designed DNA insertion packets. "Every DNA packet insertion has the potential to create a new recombinant fiber with commercial applications. The achievement of 5,000 such insertions in a single week is something that the Company would not have dreamed of in 2008," said CEO Kim K. Thompson. "At the same time," Thompson continued, "Dr. Fraser is reporting a large increase in the team's observation of the occurrence of transient expression shortly after the gene transfers are preformed." Transient expression following a genetic insertion is seen by the research team as a strong indication of the viability of the genetic transfers.
GeneThera's E. Coli Vaccine Featured on CBS, Channel 4 News In Denver, Colorado
DENVER, SAN JOSE, Calif. and BOISE, Idaho, Feb. 10, 2009 (GLOBE NEWSWIRE) -- GeneThera, Inc. (Pink Sheets:GTHR), a leading international biotechnology company dedicated to improving food safety, was recently interviewed on Denver CBS Affiliate Channel 4, KCNC-TV. The interview was conducted as a result of an E. Coli outbreak linked to the National Western Stock Show.
Primoris Services Corporation
Primoris Services Corporation Names John P. Schauerman Executive Vice President, Corporate Development and Appoints Peter J. Moerbeek Executive Vice President, Chief Financial Officer
LAKE FOREST, Calif., Feb. 10, 2009 (GLOBE NEWSWIRE) -- Primoris Services Corporation (Nasdaq:PRIM) (Nasdaq:PRIMU) (Nasdaq:PRIMW) ("Primoris" or "Company"), one of the largest specialty contractors and engineering companies in the United States, today announced that John P. Schauerman has been named to the newly created position of Executive Vice President, Corporate Development and that Peter J. Moerbeek has been named Executive Vice President, Chief Financial Officer. Both appointments were effective February 6, 2009.